Vet survey shows outlook is better - Morgan Stanley
Tweet
Share
E-mailGet Alerts ZTS Hot Sheet
Price: $77.29 --0%
Rating Summary:
18 Buy, 15 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 3
Rating Summary:
18 Buy, 15 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 3
Join SI Premium – FREE
Morgan Stanley analyst Erin Wright notes a proprietary AlphaWise US vet survey points to sequentially lighter 1Q demand, but they are encouraged the NTM and next quarter's outlook are trending upward.
The firm favors Zoetis (NYSE: ZTS) and IDEXX Labs (NASDAQ: IDXX) into earnings, despite the recent moves higher in the stocks.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
- UBS Downgrades SAP (SAP:GR) (SAP) to Neutral
- Morgan Stanley Double Downgrades Gujarat Energy (GUJENERG:IN) to Underweight
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Morgan Stanley, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
